Revenue from Contracts with Customers (Tables)

9 Months Ended

Sep. 26, 2025

Revenue from Contract with Customer [Abstract]

Rollforward of Variable Consideration Reserves

The following table reflects activity in the Company's sales reserve accounts:

	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 29, 2023	$	201.6	$	14.5	$	11.3	$	227.4
Provisions	1,206.2		15.9		43.6		1,265.7
Payments or credits	(1,206.9)		(15.8)		(34.9)		(1,257.6)
Balance as of September 27, 2024	$	200.9	$	14.6	$	20.0	$	235.5
Balance as of December 27, 2024	$	197.5	$	14.8	$	16.5	$	228.8
Acquisitions (Note 3)	286.6		91.2		19.6		397.4
Provisions	1,493.4		18.9		51.2		1,563.5
Payments or credits	(1,451.7)		(16.3)		(59.4)		(1,527.4)
Balance as of September 26, 2025	$	525.8	$	108.6	$	27.9	$	662.3

Schedule of Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:

	Three Months Ended				Nine Months Ended
	September 26, 2025		September 27, 2024		September 26, 2025		September 27, 2024
Product sales transferred at a point in time	92.2	%	87.1	%	88.9	%	86.2	%
Product sales transferred over time	7.8		12.9		11.1		13.8

Schedule of Transaction Price Allocated to the Remaining Performance Obligations

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of September 26, 2025:

Remainder of Fiscal 2025	79.1
Fiscal 2026	76.3
Fiscal 2027	37.3
Thereafter	15.2

Schedule of Costs to Fulfill a Contract

The associated depreciation expense recognized was as follows:

	Three Months Ended				Nine Months Ended
	September 26, 2025		September 27, 2024		September 26, 2025		September 27, 2024
Depreciation expense	$	1.6	$	0.5	$	4.5	$	1.2